Gene: GLCCI1
Official Full Name: glucocorticoid induced 1provided by HGNC
Gene Summary: This gene encodes a protein of unknown function. Expression of this gene is induced by glucocorticoids and may be an early marker for glucocorticoid-induced apoptosis. Single nucleotide polymorphisms in this gene are associated with a decreased response to inhaled glucocorticoids in asthmatic patients. [provided by RefSeq, Feb 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30851 | GLCCI1 Knockout cell line (HeLa) | Human | GLCCI1 | 1:3~1:6 | Negative | Online Inquiry |
KO30852 | GLCCI1 Knockout cell line (HCT 116) | Human | GLCCI1 | 1:2~1:4 | Negative | Online Inquiry |
KO30853 | GLCCI1 Knockout cell line (HEK293) | Human | GLCCI1 | 1:3~1:6 | Negative | Online Inquiry |
KO30854 | GLCCI1 Knockout cell line (A549) | Human | GLCCI1 | 1:3~1:4 | Negative | Online Inquiry |
GLCCI1 Gene Knockout Cell Lines are specifically engineered cellular models that lack the expression of the GLCCI1 gene, which encodes for a protein implicated in the modulation of glucocorticoid responses in the immune system. These cell lines serve as an essential tool in understanding the biological functions of the GLCCI1 gene and its association with various pathophysiological conditions, including asthma and other inflammatory diseases. By providing a "knockout" model, researchers can examine the consequences of the absence of GLCCI1, allowing for a clearer investigation into its role in cell signaling pathways and therapeutic responses.
The key function of GLCCI1 Gene Knockout Cell Lines lies in their ability to simulate disease-like conditions in vitro, enabling scientists to elucidate the mechanisms of glucocorticoid resistance and sensitivity. When subjected to glucocorticoid treatment, these knockout cells exhibit differential responses compared to wild-type cell lines, making them invaluable in drug screening and therapeutic development. Their use in various assays, such as gene expression profiling and protein interaction studies, provides insights into how the GLCCI1 gene moderates immune responses and can aid in the search for targeted therapies.
The scientific importance of these cell lines extends beyond basic research to clinical applications as they offer a platform for developing personalized medicine strategies. With an emphasis on clinically relevant models, researchers can use GLCCI1 knockout lines to evaluate new treatment modalities that might overcome glucocorticoid resistance in patients with respiratory diseases.
Compared to traditional cell culture systems, GLCCI1 Gene Knockout Cell Lines provide specific advantages, such as the ability to model the loss-of-function mutations directly and a closer approximation to in vivo conditions. This specificity enhances data reliability and reproducibility, which are critical for advancing translational research.
For researchers and clinicians, the value of GLCCI1 Gene Knockout Cell Lines lies in their potential to drive discoveries that pave the way for novel therapeutic strategies. Our company specializes in developing high-quality, precisely engineered knockout cell lines, ensuring researchers have reliable and innovative tools for their studies. We are committed to supporting scientific advancement by providing products that facilitate groundbreaking research in gene function and therapeutic interventions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.